Fig. 5. Paclitaxel decreases the production of tumor necrosis factor-alpha (TNF-α) and IL-10 of LPS-activated spleen cells. The cells were treated with 5-fold serial dilutions of LPS and 5.0 µg/mL paclitaxel for 3 days in 96-well culture plates, after which the culture supernatants were used for TNF-α and IL-10 enzyme-linked immunosorbent assay. Data are presented as the means ± SD.
